Manyi Xu

Discovery of Novel Celastrol Derivatives as Hsp90–Cdc37 Interaction Disruptors with Antitumor Activity

Na Li, Manyi Xu, Bing Wang et al. · Journal of Medicinal Chemistry · 2019 · 38 citations

Novel NO-releasing plumbagin derivatives: Design, synthesis and evaluation of antiproliferative activity

Na Bao, Jinfeng Ou, Manyi Xu et al. · European Journal of Medicinal Chemistry · 2017 · 26 citations

Medicinal Chemistry, Pharmaceutical Science, Biochemistry +8

Design, synthesis and antitumor evaluation of novel celastrol derivatives

Manyi Xu, Na Li, Zihao Zhao et al. · European Journal of Medicinal Chemistry · 2019 · 24 citations

Medicinal Chemistry, Pharmaceutical Chemistry, Anti-cancer Agent +3

Discovery of Novel Celastrol–Imidazole Derivatives with Anticancer Activity <i>In Vitro</i> and <i>In Vivo</i>

Na Li, Manyi Xu, Lulu Zhang et al. · Journal of Medicinal Chemistry · 2022 · 21 citations

Discovery of novel NO-releasing celastrol derivatives with Hsp90 inhibition and cytotoxic activities

Na Li, Manyi Xu, Na Bao et al. · European Journal of Medicinal Chemistry · 2018 · 13 citations

Medicinal Chemistry, Cytotoxic Activities, Medicine +4